BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30792527)

  • 1. Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation.
    Mir H; Kaur G; Kapur N; Bae S; Lillard JW; Singh S
    Sci Rep; 2019 Feb; 9(1):2527. PubMed ID: 30792527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways.
    Han J; Fu R; Chen C; Cheng X; Guo T; Huangfu L; Li X; Du H; Xing X; Ji J
    Int J Biol Sci; 2021; 17(11):2841-2852. PubMed ID: 34345211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated macrophages promote the metastasis of ovarian carcinoma cells by enhancing CXCL16/CXCR6 expression.
    Hong L; Wang S; Li W; Wu D; Chen W
    Pathol Res Pract; 2018 Sep; 214(9):1345-1351. PubMed ID: 30049511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
    Guo L; Cui ZM; Zhang J; Huang Y
    Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell-derived CXCL16 promotes progression of gastric cancer cells by STAT3-mediated expression of Ror1.
    Ikeda T; Nishita M; Hoshi K; Honda T; Kakeji Y; Minami Y
    Cancer Sci; 2020 Apr; 111(4):1254-1265. PubMed ID: 32012403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity.
    Gooden MJ; Wiersma VR; Boerma A; Leffers N; Boezen HM; ten Hoor KA; Hollema H; Walenkamp AM; Daemen T; Nijman HW; Bremer E
    Br J Cancer; 2014 Mar; 110(6):1535-44. PubMed ID: 24518602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases.
    Korbecki J; Bajdak-Rusinek K; Kupnicka P; Kapczuk P; Simińska D; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33800554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
    Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
    Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro.
    Hu W; Liu Y; Zhou W; Si L; Ren L
    PLoS One; 2014; 9(6):e99056. PubMed ID: 24897301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance and biological function of lncRNA SOCAR in serous ovarian carcinoma.
    Guo Q; Wang L; Zhu L; Lu X; Song Y; Sun J; Wu Z; Shi J; Wang Z; Zhou X
    Gene; 2019 Sep; 713():143969. PubMed ID: 31299360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL16/CXCR6 axis promotes bleomycin-induced fibrotic process in MRC-5 cells via the PI3K/AKT/FOXO3a pathway.
    Ma Z; Yu R; Zhu Q; Sun L; Jian L; Wang X; Zhao J; Li C; Liu X
    Int Immunopharmacol; 2020 Apr; 81():106035. PubMed ID: 31753588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16.
    Adamski V; Mentlein R; Lucius R; Synowitz M; Held-Feindt J; Hattermann K
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
    Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
    World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional role of endothelial CXCL16/CXCR6-platelet-leucocyte axis in angiotensin II-associated metabolic disorders.
    Collado A; Marques P; Escudero P; Rius C; Domingo E; Martinez-Hervás S; Real JT; Ascaso JF; Piqueras L; Sanz MJ
    Cardiovasc Res; 2018 Nov; 114(13):1764-1775. PubMed ID: 29800106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel.
    Kapur N; Mir H; Sonpavde GP; Jain S; Bae S; Lillard JW; Singh S
    Cancer Lett; 2019 Jul; 454():1-13. PubMed ID: 30974114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases.
    Mir H; Singh R; Kloecker GH; Lillard JW; Singh S
    Oncotarget; 2015 Apr; 6(12):9985-98. PubMed ID: 25888629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic diversification of chemokine CXCL16 and its receptor CXCR6 in primates.
    Xu F; He D; Liu J; Ni Q; Lyu Y; Xiong S; Li Y
    Dev Comp Immunol; 2018 Aug; 85():86-94. PubMed ID: 29635005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the CXCL16/CXCR6 Axis by TNF-α Contributes to Ectopic Endometrial Stromal Cells Migration and Invasion.
    Peng Y; Ma J; Lin J
    Reprod Sci; 2019 Mar; 26(3):420-427. PubMed ID: 29779473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16-CXCR6 axis.
    Takiguchi G; Nishita M; Kurita K; Kakeji Y; Minami Y
    Cancer Sci; 2016 Mar; 107(3):290-7. PubMed ID: 26708384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering.
    Singh R; Kapur N; Mir H; Singh N; Lillard JW; Singh S
    Oncotarget; 2016 Feb; 7(6):7343-53. PubMed ID: 26799186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.